26 Sep 2005

The PATH Malaria Vaccine Initiative Welcomes ExxonMobil Grant to Speed Malaria Vaccine Development

Bethesda, Maryland, USA (Monday, 26 September 2005) – Noting that Africa continues to grapple with the daily loss of 3,000 children to malaria, the PATH Malaria Vaccine Initiative (MVI) welcomed the $500,000 grant announced today by ExxonMobil to support efforts to promote greater investment in the development of a life-saving vaccine.